Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celldex Therapeutics Inc (NASDAQ:CLDX)

4.22
BATS BZX Real-Time Price
As of 11:02am ET
 +0.005 / +0.12%
Today’s Change
2.96
Today|||52-Week Range
29.94
-73.05%
Year-to-Date
3 Reasons Celldex Therapeutics Stock Could Rise
May 23 / MotleyFool.com - Paid Partner Content
5 Top Biotech Stocks to Buy on Sale
May 17 / MotleyFool.com - Paid Partner Content
3 Healthcare Stocks Bears Are Wrong About
May 18 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close4.22
Today’s open4.29
Day’s range4.14 - 4.29
Volume30,011
Average volume (3 months)4,039,339
Market cap$416.6M
Dividend yield--
Data as of 11:02am ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-1.87%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
UBICUBIC Inc-0.46-2.40%
MGMistras Group Inc-0.05-0.20%
FCSCFibrocell Science In...0.000.00%
RNVARennova Health Inc+0.02+3.43%
Data as of 10:46am ET, 05/26/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts

Partner Offers

Search for Jobs